COVID-19 vaccines shown to reduce SARS-CoV-2 infection rate in cancer patients

By | December 6, 2021
A study recently published in the journal JAMA Oncology has stated that coronavirus disease 2019 (COVID-19) vaccines are more than 55% effective in reducing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in cancer patients.